Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:06:23 EDT Fri 04 Jul 2025
Enter Symbol
or Name
USA
CA



Q:BLRX - BIOLINE RX LTD SPON ADR EACH REP 600 ORD SHS (P/S) - https://www.biolinerx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BLRX - Q0.14.26·4.650.54.49    35.60  2.3001Jul 03May 2715 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-27 07:00U:BLRXNews ReleaseBioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-20 07:00U:BLRXNews ReleaseBioLineRx to Report First Quarter 2025 Results on May 27, 2025
2025-03-31 07:00U:BLRXNews ReleaseBioLineRx Reports 2024 Financial Results and Provides Corporate Update
2025-01-21 07:00U:BLRXNews ReleaseBioLineRx Issues Letter to Shareholders
2025-01-17 07:00U:BLRXNews ReleaseBioLineRx Announces Change to Ratio of American Depositary Shares to Ordinary Shares
2025-01-06 08:55U:BLRXNews ReleaseBioLineRx Announces $10 Million Registered Direct Offering
2024-11-25 07:00U:BLRXNews ReleaseBioLineRx Reports Third Quarter 2024 Financial Results and Provides Update on Transformation to Drive Shareholder Value
2024-11-21 06:30U:BLRXNews ReleaseBioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA(TM) (motixafortide) through Gamida Cell Ltd.
2024-11-20 07:19U:BLRXNews ReleaseBioLineRx to Report Third Quarter 2024 Results on November 25, 2024
2024-11-05 09:00U:BLRXNews ReleaseBioLineRx Announces Oral Presentation on Data from Phase 1 Clinical Trial Evaluating Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease at ASH 2024
2024-09-17 13:01U:BLRXNews ReleaseBioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection
2024-08-15 07:00U:BLRXNews ReleaseBioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
2024-08-08 07:00U:BLRXNews ReleaseBioLineRx to Report Second Quarter 2024 Results on August 15, 2024